Getting denied for Wegovy or Ozempic coverage is frustrating, but it’s also common, and it’s not the end of the road. Insurance denials for GLP-1 medications are successfully overturned regularly, particularly when the appeal is well-documented and the clinical case is strong. The process takes time and some persistence, but understanding exactly how it works puts you in a much better position to get the outcome you need.<\/p>\n
Before getting into how to appeal, it helps to understand why denials happen. The most common reasons include:<\/p>\n
Prior authorization wasn’t submitted or was incomplete. Some denials happen simply because the paperwork wasn’t submitted correctly or was missing clinical documentation the insurer requires.<\/p>\n
The plan excludes weight loss medications entirely. Some plans, particularly individual marketplace plans and certain employer plans, exclude GLP-1 medications from coverage regardless of clinical need. These are harder to appeal but not impossible, particularly if you have a qualifying comorbidity that reframes the indication.<\/p>\n
Step therapy requirements weren’t met. Your plan may require documentation that you’ve tried less expensive medications first before approving a GLP-1.<\/p>\n
BMI or comorbidity criteria weren’t documented. Even if you meet the clinical threshold, the insurer needs your provider to document it explicitly. If the chart notes don’t clearly state your BMI and relevant conditions, the prior authorization reviewer may not have what they need to approve.<\/p>\n
The prescription was written for the wrong indication. Ozempic prescribed for weight loss in a patient without a diabetes diagnosis may be denied if the plan only covers it for diabetes management.<\/p>\n
Knowing which of these applies to your denial shapes how you build the appeal.<\/p>\n
Your insurer is required to send a written explanation of why your claim was denied. Read it carefully. The denial letter will specify the reason for the denial and reference the specific plan criteria or policy that wasn’t met. This is your roadmap for the appeal.<\/p>\n
Common denial reasons you’ll see include “not medically necessary,” “criteria not met,” “excluded benefit,” or “step therapy requirements not satisfied.” Each of these points to a different type of documentation you’ll need to address in the appeal.<\/p>\n
The denial letter will also tell you the deadline for filing an appeal. These deadlines are real. Missing them can forfeit your right to appeal, so note the date and start the process promptly.<\/p>\n
You have the right to request the specific clinical criteria your insurer uses to evaluate prior authorization for the medication in question. Ask for the full prior authorization criteria document for semaglutide or tirzepatide. This tells you exactly what threshold you need to meet and what documentation will satisfy it.<\/p>\n
Compare those criteria against what your provider submitted. The gap between what was submitted and what the criteria require is what your appeal needs to close.<\/p>\n
This is the most important part of the appeal. A strong appeal is not just a letter saying you disagree with the decision. It’s a package of clinical evidence that directly addresses each reason for denial.<\/p>\n
Your provider needs to be your partner in this process. The appeal documentation typically includes:<\/p>\n
A letter of medical necessity from your prescribing provider. This should explicitly state your BMI, any weight-related comorbidities such as hypertension, prediabetes, sleep apnea, or cardiovascular disease, your history of weight loss attempts, and a clear clinical argument for why this specific medication is appropriate for your situation. The more specific and individualized this letter is, the stronger it is.<\/p>\n
Relevant lab results and clinical records. Fasting glucose, HbA1c, lipid panel, blood pressure readings, and any other objective data that supports the medical necessity argument. How to read your semaglutide lab results<\/a> is a useful reference for understanding which values matter most in this context.<\/p>\n Documentation of prior weight loss attempts. If the denial cited step therapy or insufficient prior attempts, your provider should document any structured diet programs, behavioral interventions, or other medications you’ve tried. Even if these weren’t formal clinical programs, your provider can document the history from your medical record.<\/p>\n Research supporting the medication’s efficacy and safety for your indication. For cardiovascular risk specifically, the SELECT trial data is directly relevant. For metabolic conditions like prediabetes or PCOS, there’s a growing body of evidence your provider can reference.<\/p>\n Most insurance plans have a multi-level internal appeals process. The first level is an internal review by the insurer’s medical staff. Submit your complete documentation package along with a cover letter that clearly identifies the denial reason and explains how your documentation addresses each point.<\/p>\n Be specific and organized. If the denial cited three reasons, address each one explicitly. Reviewers are working through many appeals, and a clearly structured submission is easier to approve than one that buries the key information.<\/p>\n Internal appeals at the first level are typically resolved within 30 days for standard appeals, or 72 hours for urgent cases. If your situation involves an active medical need and a delay would cause harm, ask your provider to flag the appeal as urgent.<\/p>\n If the first internal appeal is denied, most plans allow a second-level internal review. This is typically reviewed by a different set of clinical reviewers than the first. Submit any additional documentation your provider can provide, and if possible, include peer-reviewed research supporting the clinical case.<\/p>\n At this stage it’s also worth asking your provider whether a peer-to-peer review is available. A peer-to-peer review allows your prescribing provider to speak directly with the insurer’s medical reviewer. These conversations can be surprisingly effective, particularly when the clinical case is strong and your provider can advocate directly for the treatment decision.<\/p>\n If both internal appeal levels are denied, you have the right to request an external independent review. An external reviewer is a neutral third party with no financial relationship to your insurer. They evaluate the clinical merits of the case on their own.<\/p>\n External reviews are more favorable to patients than many people expect. When the clinical documentation is strong and the denial was based on a narrow reading of criteria rather than a genuine absence of medical need, external reviewers frequently overturn the insurer’s decision.<\/p>\n Request the external review in writing within the deadline specified in your second denial letter. Your state insurance commissioner’s office can provide information on the external review process if you need guidance.<\/p>\n Some denials can’t be overturned, particularly when the plan genuinely excludes weight loss medications as a benefit. If that’s where you land, the practical alternative is compounded semaglutide or tirzepatide through a telehealth provider, which is accessible at cash pay prices substantially lower than brand-name medications without insurance.<\/p>\n How to get GLP-1 medications without insurance<\/a> covers the full range of options, and explore compounded semaglutide at TrimRx<\/a> to see current pricing and what telehealth access looks like without insurance involvement.<\/p>\n It’s also worth noting that if your employer sponsors your plan, raising the coverage gap with your HR department is worth doing. Employer benefit decisions respond to employee demand, and enough requests for GLP-1 coverage have prompted employers to add it. Your appeal process and the outcome becomes useful data in that conversation.<\/p>\nStep Four: Submit the Internal Appeal<\/h2>\n
Step Five: Second-Level Internal Appeal<\/h2>\n
Step Six: External Independent Review<\/h2>\n
If the Appeal Is Ultimately Unsuccessful<\/h2>\n